Free Trial
NASDAQ:APDN

Applied DNA Sciences Q2 2025 Earnings Report

Applied DNA Sciences logo
$4.72 -0.04 (-0.84%)
Closing price 06/25/2025 04:00 PM Eastern
Extended Trading
$4.65 -0.07 (-1.46%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Applied DNA Sciences EPS Results

Actual EPS
-$230.25
Consensus EPS
-$45.00
Beat/Miss
Missed by -$185.25
One Year Ago EPS
N/A

Applied DNA Sciences Revenue Results

Actual Revenue
$0.98 million
Expected Revenue
$1.19 million
Beat/Miss
Missed by -$202.00 thousand
YoY Revenue Growth
N/A

Applied DNA Sciences Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Thursday, May 15, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

Applied DNA Sciences' Q3 2025 earnings is scheduled for Wednesday, August 6, 2025

Applied DNA Sciences Earnings Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Applied DNA regains compliance with Nasdaq minimum bid price rule
Why Applied DNA Sciences (APDN) Stock Is Rising
See More Applied DNA Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Applied DNA Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Applied DNA Sciences and other key companies, straight to your email.

About Applied DNA Sciences

Applied DNA Sciences (NASDAQ:APDN), Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

View Applied DNA Sciences Profile

More Earnings Resources from MarketBeat